Provided by Tiger Trade Technology Pte. Ltd.

Seres Therapeutics

9.00
-0.3300-3.54%
Post-market: 9.350.3500+3.89%18:59 EDT
Volume:34.31K
Turnover:313.13K
Market Cap:86.28M
PE:14.06
High:9.53
Open:9.23
Low:8.94
Close:9.33
52wk High:29.98
52wk Low:6.53
Shares:9.59M
Float Shares:7.29M
Volume Ratio:0.64
T/O Rate:0.47%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.6400
EPS(LYR):0.0175
ROE:19.64%
ROA:-42.25%
PB:1.95
PE(LYR):514.20

Loading ...

May 04, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 04, 2022

Major Issues Report

8-K - Current report
Apr 06, 2022

Major Issues Report

8-K - Current report
Mar 01, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 01, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 01, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 04, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 10, 2021

Major Issues Report

8-K - Current report
Nov 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 03, 2021

Major Issues Report

8-K - Current report
Aug 03, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 22, 2021

Major Issues Report

8-K - Current report
Jul 01, 2021

Major Issues Report

8-K - Current report
Jun 21, 2021

Major Issues Report

8-K - Current report
May 21, 2021

Major Issues Report

8-K - Current report
May 20, 2021

Major Issues Report

8-K - Current report